Identification of phytochemicals and evaluation of anticancer activity of peels of Carica papaya fruit

Abstract

Carica papaya (C. papaya), a member of the Caricaceae family, is a significant fruit crop grown in tropical and subtropical regions. The several constituents of C. papaya leaves, barks, roots, latex, fruit, flowers, and seeds have been widely acknowledged for their potential therapeutic use in traditional medicine. This study aimed to identify the phytoconstituents and evaluation of in silico and in vitro anti-cancer activity of the ethanolic extract of C. papaya fruit peel. Q-TOF LC-MS analysis was done in order to ascertain phytoconstituents in the C. papaya fruit peel extract. Through the use of molecular docking studies, the anticancer activity of the identified phytoconstituent, myo-inositol, was studied in a virtual environment. We used the breast cancer cell line MDA-MB-231 to determine the in vitro anticancer activity through the MTT assay. Myo-inositol, identified through LC-MS analysis, plays an essential role in the facilitation of a number of cellular functions. The molecular docking analysis of myo-inositol with inhibitor of apoptosis protein (AIP) reveals that it has a strong interaction with docking scores of -10.45 Kcal/mol (5M6E), -12.32 Kcal/mol (5M6M), and 9.64 Kcal/mol (5M6N). In MTT assay, the extract at various doses exhibited cytotoxic effects on MDA-MB-23, with an IC50 value of 241.708 ± 8.052 µg/mL. In the morphological analysis, the treatment group showed shrinkage, detachment, membrane blebbing, and twisted form, which were not seen in the control group. The study reveals the LC-MS analysis of C. papaya fruit peel's phytoconstituents, which inhibit breast cancer cell proliferation, and their potential for use in cancer treatment.

Keywords

• Anticancer activity
• Carica papaya
• MDA-MB-231
• molecular docking
• MTT assay
• Q-TOF LC-MS analysis

References

1. [1] Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, CA: Cancer J Clin. 2014;64(1): 9-29. https://doi.org/10.3322/caac.21208
2. [2] Al-Hussaniy HA. The effect of MicroRNA-409-3p for treatment and response to tumor proliferation of lung cancer cell lines (in vitro). Asian Pac J Cancer Prev. 2022;23(9):31-51. https://doi.org/10.31557%2FAPJCP.2022.23.9.3151
3. [3] Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan S, Roselind FS, Icmr-Ncdir-Ncrp Investigator Group. Cancer statistics, 2020: report from national cancer registry programme, India. JCO Glob Oncol. 2020;6:1063-1075. https://doi.org/10.1200/go.20.00122
4. [4] Sohel M, Sultana H, Sultana T, Al Amin M, Aktar S, Ali MC, Rahim ZB, Hossain MA, Al Mamun A, Amin MN, Dash R. Chemotherapeutic potential of hesperetin for cancer treatment, with mechanistic insights: A comprehensive review. Heliyon. 2022;8(1):e08815. https://doi.org/10.1016/j.heliyon.2022.e08815
5. [5] Bhattacharya S. Development of 5-FU loaded poly lactic-co-glycolic acid nanoparticles for treatment of lung cancer. Iraqi J Pharm Sci. 2022;31(1):130-143. https://doi.org/10.31351/vol31iss1pp130-143
6. [6] Bhatia A, Singh B, Arora R, Arora S. In vitro evaluation of the α-glucosidase inhibitory potential of methanolic extracts of traditionally used antidiabetic plants. BMC Complement Altern Med. 2019;19(1):74. https://doi.org/10.1186/s12906-019-2482-z
7. [7] El Omari N, Sayah K, Fettach S, El Blidi O, Bouyahya A, Faouzi ME, Kamal R, Barkiyou M. Evaluation of in vitro antioxidant and antidiabetic activities of Aristolochia longa extracts. Evid Based Complement Alternat Med. 2019;2019(1):7384735. https://doi.org/10.1155/2019/7384735
8. [8] Oboh G, Olabiyi AA, Akinyemi AJ, Ademiluyi AO. Inhibition of key enzymes linked to type 2 diabetes and sodium nitroprusside-induced lipid peroxidation in rat pancreas by water-extractable phytochemicals from unripe pawpaw fruit (Carica papaya). J Basic Clin Physiol Pharmacol. 2014;25(1):21-34. https://doi.org/10.1515/jbcpp-2013-0002

9. [9] Sabiu S, Ashafa AO. Membrane stabilization and kinetics of carbohydrate metabolizing enzymes (α-amylase and α- glucosidase) inhibitory potentials of Eucalyptus obliqua L. Her.(Myrtaceae) Blakely ethanolic leaf extract: An in vitro assessment. South Afr J Bot. 2016;105:264-269. https://doi.org/10.1016/j.sajb.2016.04.007
10. [10] Thitilertdecha N, Teerawutgulrag A, Rakariyatham N. Antioxidant and antibacterial activities of Nephelium lappaceum L. extracts. LWT-Food Sci Technol. 2008;41(10):2029-2035.
11. [11] Al-Zoreky NS. Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels. Int J Food Microbiol. 2009;134(3):244-248. https://doi.org/10.1016/j.ijfoodmicro.2009.07.002
12. [12] Malleshappa P, Kumaran RC, Venkatarangaiah K, Parveen S. Peels of citrus fruits: A potential source of anti- inflammatory and anti-nociceptive agents. Phcog J. 2018;10(6s):172-178. http://dx.doi.org/10.5530/pj.2018.6s.30
13. [13] Liu X, Yu L, Li W, Peng D, Zhong L, Li L, Xin Q, Lu H, Yu C, Gong P. Comparison of country-level cropland areas between ESA-CCI land cover maps and FAOSTAT data. Int J Remote Sens. 2018;39(20):6631-6645. http://dx.doi.org/10.1080/01431161.2018.1465613
14. [14] Hewitt H, Whittle S, Lopez S, Bailey E, Weaver S. Topical use of papaya in chronic skin ulcer therapy in Jamaica. West Indian Med J. 2000;49(1):32-33.
15. [15] Lim TK. Edible medicinal and non-medicinal plants, First ed.,Dordrecht, The Netherlands:: Springer; 2012.
16. [16] Krishna KL, Paridhavi M, Patel JA. Review on nutritional, medicinal and pharmacological properties of Papaya (Carica papaya Linn.). Nat Prod Rad. 2008; 7(4):364-373.
17. [17] Otsuki N, Dang NH, Kumagai E, Kondo A, Iwata S, Morimoto C. Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects. J Ethnopharmacol. 2010;127(3):760-767. https://doi.org/10.1016/j.jep.2009.11.024
18. [18] Al-Seadi HL, Sabti MZ, Taain DA. GC-MS analysis of papaya leaf extract (Carica papaya L.). IOP Conf Ser. 2021; 910(1): 012011. https://doi.org/10.1088/1755-1315/910/1/012011
19. [19] Eagle H, Oyama VI, Levy M, Freeman AE. Myo-Inositol as an essential growth factor for normal and malignant human cells in tissue culture. J Biol Chem. 1957;226(1):191-205.
20. [20] Chau JF, Lee MK, Law JW, Chung SK, Chung SS. Sodium/myo‐inositol cotransporter‐1 is essential for the development and function of the peripheral nerves. FASEB J. 2005 ;19(13):1887-1889. https://doi.org/10.1096/fj.05- 4192fje
21. [21] Dai Z, Chung SK, Miao D, Lau KS, Chan AW, Kung AW. Sodium/myo‐inositol cotransporter 1 and myo‐inositol are essential for osteogenesis and bone formation. J Bone Miner Res. 2011;26(3):582-590. https://doi.org/10.1002/jbmr.240
22. [22] Condorelli RA, La Vignera S, Bellanca S, Vicari E, Calogero AE. Myoinositol: does it improve sperm mitochondrial function and sperm motility?. J Urology. 2012;79(6):1290-1295. https://doi.org/10.1016/j.urology.2012.03.005
23. [23] Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci. 2011;15(5): 509-514.
24. [24] Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Eur Rev Med Pharmacol Sci. 2011;15(4): 452-457.
25. [25] Archna, Chawla PA, Teli G, Pathania S, Singh S, Srivastava V. Exploration of antioxidant, anti-inflammatory and anticancer potential of substituted 4-thiazolidinone derivatives: Synthesis, biological evaluation and docking studies. Polycycl Aromat Comp. 2023; 43(1): 597-618. https://doi.org/10.1080/10406638.2021.2019796
26. [26] Ottanà R, Maccari R, Barreca ML, Bruno G, Rotondo A, Rossi A, Chiricosta G, Di Paola R, Sautebin L, Cuzzocrea S. 5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents. Bioorg Med Chem. 2005;13(13):4243-4252. https://doi.org/10.1016/j.bmc.2005.04.058
27. [27] Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63. https://doi.org/10.1016/0022-1759(83)90303-4